{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:32Z","timestamp":1740107732280,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-021-06012-y","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T17:02:34Z","timestamp":1643302954000},"page":"1439-1446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results"],"prefix":"10.1007","volume":"41","author":[{"given":"Gizem","family":"Ayan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayram","family":"Farisogullar\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertugrul Cagri","family":"Bolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gozde","family":"K\u00fcbraYard\u0131mc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Ozsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gullu Sandal","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Akdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eule Apra\u015f","family":"Bilgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali \u0130hsan","family":"Ertenli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-2109","authenticated-orcid":false,"given":"Umut","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"issue":"Suppl 2","key":"6012_CR1","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14\u2013ii17. https:\/\/doi.org\/10.1136\/ard.2004.032482","journal-title":"Ann Rheum Dis"},{"key":"6012_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/rheumatology\/keu398","volume":"54","author":"R Giacomelli","year":"2015","unstructured":"Giacomelli R, Gorla R, Trotta F, Tirri R, Grassi W, Bazzichi L, Galeazzi M, Matucci-Cerinic M, Scarpa R, Cantini F, Gerli R, Lapadula G, Sinigaglia L, Ferraccioli G, Olivieri I, Ruscitti P, Sarzi-Puttini P (2015) Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study. Rheumatology (Oxford) 54:792\u2013797. https:\/\/doi.org\/10.1093\/rheumatology\/keu398","journal-title":"Rheumatology (Oxford)"},{"key":"6012_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/1756-185X.13553","volume":"22","author":"N Kamalaraj","year":"2019","unstructured":"Kamalaraj N, El-Haddad C, Hay P, Pile K (2019) Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis 22:967\u2013973. https:\/\/doi.org\/10.1111\/1756-185X.13553","journal-title":"Int J Rheum Dis"},{"key":"6012_CR4","doi-asserted-by":"publisher","first-page":"673988","DOI":"10.3389\/fphar.2021.673988","volume":"12","author":"A Bernetti","year":"2021","unstructured":"Bernetti A, Agostini F, Alviti F, Giordan N, Martella F, Santilli V, Paoloni M, Mangone M (2021) New Viscoelastic Hydrogel Hymovis MO.RE. Single intra-articular injection for the treatment of knee osteoarthritis in sportsmen: safety and efficacy study results. Front Pharmacol 12:673988. https:\/\/doi.org\/10.3389\/fphar.2021.673988","journal-title":"Front Pharmacol"},{"issue":"11","key":"6012_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/biom11030356","volume":"26","author":"A de Sire","year":"2021","unstructured":"de Sire A, Agostini F, Lippi L, Mangone M, Marchese S, Cisari C, Bernetti A, Invernizzi M (2021) Oxygen-Ozone Therapy in the rehabilitation field: state of the art on mechanisms of action, safety and effectiveness in patients with musculoskeletal disorders. Biomolecules 26(11):356. https:\/\/doi.org\/10.3390\/biom11030356","journal-title":"Biomolecules"},{"key":"6012_CR6","doi-asserted-by":"publisher","first-page":"300060520986705","DOI":"10.1177\/0300060520986705","volume":"49","author":"T Paolucci","year":"2021","unstructured":"Paolucci T, Agostini F, Bernetti A, Paoloni M, Mangone M, Santilli V, Pezzi L, Bellomo RG, Saggini R (2021) Integration of focal vibration and intra-articular oxygen-ozone therapy in rehabilitation of painful knee osteoarthritis. J Int Med Res 49:300060520986705. https:\/\/doi.org\/10.1177\/0300060520986705","journal-title":"J Int Med Res"},{"key":"6012_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.23736\/S0025-7826.20.03648-0","volume":"73","author":"A Bernetti","year":"2020","unstructured":"Bernetti A, Mangone M, Paolucci T, Santilli V, Verna S, Agostini F, Paoloni M (2020) Evaluation of the efficacy of intra-articular injective treatment with reticular hyaluronic acid (Mo.Re. Technology) in amateur athletes with over-use gonarthrosis. Med Sport 73:127\u2013139. https:\/\/doi.org\/10.23736\/S0025-7826.20.03648-0","journal-title":"Med Sport"},{"key":"6012_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3899\/jrheum.130797","volume":"4","author":"E McDonough","year":"2014","unstructured":"McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 4:887\u2013896. https:\/\/doi.org\/10.3899\/jrheum.130797","journal-title":"J Rheumatol"},{"key":"6012_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.semarthrit.2020.02.001","volume":"50","author":"EZ Zusman","year":"2020","unstructured":"Zusman EZ, Howren AM, Park JYE, Dutz J, De Vera MA (2020) Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50:1481\u20131488. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.02.001","journal-title":"Semin Arthritis Rheum"},{"key":"6012_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/acr.21725","volume":"64","author":"K Kotsis","year":"2012","unstructured":"Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res (Hoboken) 64:1593\u20131601. https:\/\/doi.org\/10.1002\/acr.21725","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6012_CR11","doi-asserted-by":"publisher","unstructured":"Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V (2021) Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken) 4. https:\/\/doi.org\/10.1002\/acr.24593","DOI":"10.1002\/acr.24593"},{"key":"6012_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001303","volume":"6","author":"VK Bournia","year":"2020","unstructured":"Bournia VK, Tektonidou MG, Vassilopoulos D, Laskari K, Panopoulos S, Fragiadaki K, Mathioudakis K, Tsolakidis A, Mitrou P, Sfikakis PP (2020) Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease. RMD Open 6:e001303. https:\/\/doi.org\/10.1136\/rmdopen-2020-001303","journal-title":"RMD Open"},{"key":"6012_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrrheum.2017.81","volume":"13","author":"E Nikiphorou","year":"2017","unstructured":"Nikiphorou E, Buch MH, Hyrich KL (2017) Biologics registers in RA: methodological aspects, current role and future applications. Nat Rev Rheumatol 13:503\u2013510. https:\/\/doi.org\/10.1038\/nrrheum.2017.81","journal-title":"Nat Rev Rheumatol"},{"key":"6012_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Soo\u00e4\u00e4r I, Heiberg T, Bertheussen H, Ca\u00f1ete JD, S\u00e1nchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, B\u00e9k\u00e9s G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK, PsAID Taskforce EULAR (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73:1012\u20131019. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205207","journal-title":"Ann Rheum Dis"},{"key":"6012_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3899\/jrheum.160924","volume":"44","author":"M Di Carlo","year":"2017","unstructured":"Di Carlo M, Becciolini A, Lato V, Crotti C, Favalli EG, Salaffi F (2017) The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: construct validity, reliability, and interpretability in a clinical setting. J Rheumatol 44:279\u2013285. https:\/\/doi.org\/10.3899\/jrheum.160924","journal-title":"J Rheumatol"},{"issue":"Suppl 11","key":"6012_CR16","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/acr.20577","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ (2011) Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken) 63(Suppl 11):S64-85. https:\/\/doi.org\/10.1002\/acr.20577","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6012_CR17","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"6012_CR18","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"6012_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10067-019-04426-3","volume":"38","author":"U Kalyoncu","year":"2019","unstructured":"Kalyoncu U, Kiraz S, Bilgen SA, Karadag O, Akdogan A, Kilic L, Erden A, Armagan B, Sari A, Ertenli I (2019) Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry. Clin Rheumatol 38:1187\u20131192. https:\/\/doi.org\/10.1007\/s10067-019-04426-3","journal-title":"Clin Rheumatol"},{"issue":"4","key":"6012_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41927-020-00126-7","volume":"16","author":"H El Masri","year":"2020","unstructured":"El Masri H, Hollingworth SA, van Driel M, Benham H, McGuire TM (2020) Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center. BMC Rheumatol 16(4):27. https:\/\/doi.org\/10.1186\/s41927-020-00126-7","journal-title":"BMC Rheumatol"},{"issue":"Suppl 1","key":"6012_CR21","first-page":"1714","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L, Walsh JA, Michaud K, Holdsworth E, Peterson S, Meakin S, Bruce Wirta S, Chakravarty SD, Ogdie A (2020) AB0821 Anxiety and depression in psoriatic arthritis (PsA) - prevalence and impact on patient reported outcomes: real-world survey In The Us And Europe. Ann Rheum Dis 79(Suppl 1):1714\u20131714","journal-title":"Ann Rheum Dis"},{"key":"6012_CR22","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/annrheumdis-2017-211284","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, Wier\u00f8d A, Kalstad S, R\u00f8devand E, Kr\u00f8ll F, Haugeberg G, Kvien TK (2017) Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 76:1906\u20131910. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211284","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-06012-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:06:48Z","timestamp":1651316808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-06012-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6012"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-06012-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Ethics Committee of Hacettepe University Faculty of Medicine (No. GO 15\/788) and was performed in accordance with the ethical standards laid down in the Declaration of Helsinki of 1975\/83. Informed consent was obtained from all patients included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}